| Biologically erodable microspheres as potential oral drug delivery systems E Mathiowitz, JS Jacob, YS Jong, GP Carino, DE Chickering, ... Nature 386 (6623), 410-414, 1997 | 1082 | 1997 |
| Polymeric gene delivery system E Mathiowitz, YS Jong, K Boekelheide US Patent 6,620,617, 2003 | 317 | 2003 |
| Polymeric gene delivery E Mathiowitz, YS Jong, K Boekelheide US Patent 6,475,779, 2002 | 296 | 2002 |
| Polymeric gene delivery system E Mathiowitz, YS Jong, K Boekelheide US Patent 6,262,034, 2001 | 239 | 2001 |
| Process for preparing microparticles through phase inversion phenomena E Mathiowitz, D Chickering III, YS Jong, JS Jacob US Patent 6,143,211, 2000 | 229 | 2000 |
| In situ tumor vaccination with interleukin-12-encapsulated biodegradable microspheres: induction of tumor regression and potent antitumor immunity NK Egilmez, YS Jong, MS Sabel, JS Jacob, E Mathiowitz, RB Bankert Cancer research 60 (14), 3832-3837, 2000 | 176 | 2000 |
| Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity … HC Hill, TF Conway Jr, MS Sabel, YS Jong, E Mathiowitz, RB Bankert, ... Cancer research 62 (24), 7254-7263, 2002 | 163 | 2002 |
| Process for preparing microparticles through phase inversion phenomena E Mathiowitz, D Chickering III, YS Jong, JS Jacob US Patent 6,616,869, 2003 | 100 | 2003 |
| Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model NK Egilmez, YS Jong, Y Iwanuma, JS Jacob, CA Santos, FA Chen, ... Cancer Immunology, Immunotherapy 46, 21-24, 1998 | 77 | 1998 |
| Controlled release of plasmid DNA YS Jong, JS Jacob, KP Yip, G Gardner, E Seitelman, M Whitney, ... Journal of controlled release 47 (2), 123-134, 1997 | 74 | 1997 |
| Method for gene therapy using nucleic acid loaded polymeric microparticles E Mathiowitz, YS Jong, G Carino, JS Jacob US Patent 6,248,720, 2001 | 67 | 2001 |
| In vitro and in vivo degradation of double-walled polymer microspheres KJ Pekarek, MJ Dyrud, K Ferrer, YS Jong, E Mathiowitz Journal of Controlled Release 40 (3), 169-178, 1996 | 53 | 1996 |
| IL-12+ GM-CSF microsphere therapy induces eradication of advanced spontaneous tumors in her-2/neu transgenic mice but fails to achieve long-term cure due to the inability to … RE Nair, YS Jong, SA Jones, A Sharma, E Mathiowitz, NK Egilmez Journal of immunotherapy 29 (1), 10-20, 2006 | 48 | 2006 |
| Novel desiccants based on designed polymeric blends E Mathiowitz, JS Jacob, YS Jong, TM Hekal, W Spano, R Guemonprez, ... Journal of applied polymer science 80 (3), 317-327, 2001 | 48 | 2001 |
| Interleukin‐12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse … MA Kuriakose, FA Chen, NK Egilmez, YS Jong, E Mathiowitz, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2000 | 42 | 2000 |
| Neoadjuvant therapy with interleukin-12–loaded polylactic acid microspheres reduces local recurrence and distant metastases MS Sabel, H Hill, YS Jong, E Mathiowitz, RB Bankert, NK Egilmez Surgery 130 (3), 470-478, 2001 | 39 | 2001 |
| Human inflammatory cells within the tumor microenvironment of lung tumor xenografts mediate tumor growth suppression in situ that depends on and is augmented by interleukin-12 Y Sugiyama, M Kato, FA Chen, SS Williams, Y Kawaguchi, K Miya, ... Journal of Immunotherapy 24 (1), 37-45, 2001 | 34 | 2001 |
| Liquid crystalline polymers E Mathiowitz, JS Jacob, YS Jong, DE Chickering, EE Edwards US Patent 6,696,075, 2004 | 32 | 2004 |
| Cytokines delivered by biodegradable microspheres promote effective suppression of human tumors by human peripheral blood lymphocytes in the SCID–Winn model NK Egilmez, YS Jong, SD Hess, JS Jacob, E Mathiowitz, RB Bankert Journal of Immunotherapy 23 (2), 190-195, 2000 | 32 | 2000 |
| Tumor vaccination with cytokine-encapsulated microspheres NK Egilmez, YS Jong, E Mathiowitz, RB Bankert Lung Cancer: Volume 2: Diagnostic and Therapeutic Methods and Reviews, 687-696, 2003 | 24 | 2003 |
